Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease von Khan, Reenam S., Bril, Fernando, Cusi, Kenneth, Newsome, Philip N.

Volltext

A concise review of non-alcoholic fatty liver disease von Than, Nwe Ni, Newsome, Philip N

Volltext

Incretins (GLP-1 receptor agonists and dual/triple agonists) and the liver von Newsome, Philip N, Ambery, Phil

Volltext

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis von Newsome, Philip N, Buchholtz, Kristine, Cusi, Kenneth, Linder, Martin, Okanoue, Takeshi, Ratziu, Vlad, Sanyal, Arun J, Sejling, Anne-Sophie, Harrison, Stephen A

Volltext

Mesenchymal stromal cell therapy for liver diseases von Alfaifi, Mohammed, Eom, Young Woo, Newsome, Philip N., Baik, Soon Koo

Volltext

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis von Harrison, Stephen A., Bedossa, Pierre, Guy, Cynthia D., Schattenberg, Jörn M., Loomba, Rohit, Taub, Rebecca, Labriola, Dominic, Moussa, Sam E., Neff, Guy W., Rinella, Mary E., Anstee, Quentin M., Abdelmalek, Manal F., Younossi, Zobair, Baum, Seth J., Francque, Sven, Charlton, Michael R., Newsome, Philip N., Lanthier, Nicolas, Schiefke, Ingolf, Mangia, Alessandra, Pericàs, Juan M., Patil, Rashmee, Sanyal, Arun J., Noureddin, Mazen, Bansal, Meena B., Alkhouri, Naim, Castera, Laurent, Rudraraju, Madhavi, Ratziu, Vlad

Volltext

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement von Eslam, Mohammed, Newsome, Philip N., Sarin, Shiv K., Anstee, Quentin M., Targher, Giovanni, Romero-Gomez, Manuel, Zelber-Sagi, Shira, Wai-Sun Wong, Vincent, Dufour, Jean-François, Schattenberg, Jörn M., Kawaguchi, Takumi, Arrese, Marco, Valenti, Luca, Shiha, Gamal, Tiribelli, Claudio, Yki-Järvinen, Hannele, Fan, Jian-Gao, Grønbæk, Henning, Yilmaz, Yusuf, Cortez-Pinto, Helena, Oliveira, Claudia P., Bedossa, Pierre, Adams, Leon A., Zheng, Ming-Hua, Fouad, Yasser, Chan, Wah-Kheong, Mendez-Sanchez, Nahum, Ahn, Sang Hoon, Castera, Laurent, Bugianesi, Elisabetta, Ratziu, Vlad, George, Jacob

Volltext

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper von Boettler, Tobias, Newsome, Philip N., Mondelli, Mario U., Maticic, Mojca, Cordero, Elisa, Cornberg, Markus, Berg, Thomas

Volltext

Glucagon-Like Peptide-1 Receptor Agonists in Patients With Cirrhosis: Answering the Unanswered Questions? von Mahgoub, Sara, Newsome, Philip N.

Volltext

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study von Armstrong, Matthew James, PhD, Gaunt, Piers, MSc, Aithal, Guruprasad P, PhD, Barton, Darren, BSc, Hull, Diana, MSc, Parker, Richard, MBChB, Hazlehurst, Jonathan M, MBChB, Guo, Kathy, MSc, Abouda, George, MBChB, Aldersley, Mark A, PhD, Stocken, Deborah, PhD, Gough, Stephen C, Prof, Tomlinson, Jeremy W, Prof, Brown, Rachel M, MBChB, Hübscher, Stefan G, Prof, Newsome, Philip N, Prof

Volltext

Bariatric–metabolic surgery versus lifestyle intervention in non-alcoholic steatohepatitis von Mahgoub, Sara, Newsome, Philip N

Volltext

Guidelines on the management of abnormal liver blood tests von Newsome, Philip N, Cramb, Rob, Davison, Suzanne M, Dillon, John F, Foulerton, Mark, Godfrey, Edmund M, Hall, Richard, Harrower, Ulrike, Hudson, Mark, Langford, Andrew, Mackie, Anne, Mitchell-Thain, Robert, Sennett, Karen, Sheron, Nicholas C, Verne, Julia, Walmsley, Martine, Yeoman, Andrew

Volltext

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease von Eddowes, Peter J., Sasso, Magali, Allison, Michael, Tsochatzis, Emmanouil, Anstee, Quentin M., Sheridan, David, Guha, Indra N., Cobbold, Jeremy F., Deeks, Jonathan J., Paradis, Valérie, Bedossa, Pierre, Newsome, Philip N.

Volltext

Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis von Sanyal, Arun J., Ratziu, Vlad, Loomba, Rohit, Anstee, Quentin M., Kowdley, Kris V., Rinella, Mary E., Sheikh, Muhammad Y., Trotter, James F., Knapple, Whitfield, Lawitz, Eric J., Abdelmalek, Manal F., Newsome, Philip N., Boursier, Jérôme, Mathurin, Philippe, Dufour, Jean-François, Berrey, M. Michelle, Shiff, Steven J., Sawhney, Sangeeta, Capozza, Thomas, Leyva, Rina, Harrison, Stephen A., Younossi, Zobair M.

Volltext

Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores von Sanyal, Arun J., Foucquier, Julie, Younossi, Zobair M., Harrison, Stephen A., Newsome, Philip N., Chan, Wah-Kheong, Yilmaz, Yusuf, De Ledinghen, Victor, Costentin, Charlotte, Zheng, Ming-Hua, Wai-Sun Wong, Vincent, Elkhashab, Magdy, Huss, Ryan S., Myers, Robert P., Roux, Marine, Labourdette, Aymeric, Destro, Marie, Fournier-Poizat, Céline, Miette, Véronique, Sandrin, Laurent, Boursier, Jérôme

Volltext

Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells von de Witte, Samantha F.H., Luk, Franka, Sierra Parraga, Jesus M., Gargesha, Madhu, Merino, Ana, Korevaar, Sander S., Shankar, Anusha S., O'Flynn, Lisa, Elliman, Steve J., Roy, Debashish, Betjes, Michiel G.H., Newsome, Philip N., Baan, Carla C., Hoogduijn, Martin J.

Volltext

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests von Boursier, Jérôme, Roux, Marine, Costentin, Charlotte, Chaigneau, Julien, Fournier-Poizat, Céline, Trylesinski, Aldo, Canivet, Clémence M., Michalak, Sophie, Le Bail, Brigitte, Paradis, Valérie, Bedossa, Pierre, Sturm, Nathalie, de Ledinghen, Victor, Newsome, Philip N.

Volltext

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis von Taylor, Rod S., Taylor, Rebecca J., Bayliss, Sue, Hagström, Hannes, Nasr, Patrik, Schattenberg, Jorn M., Ishigami, Masatoshi, Toyoda, Hidenori, Wai-Sun Wong, Vincent, Peleg, Noam, Shlomai, Amir, Sebastiani, Giada, Seko, Yuya, Bhala, Neeraj, Younossi, Zobair M., Anstee, Quentin M., McPherson, Stuart, Newsome, Philip N.

Volltext

A multisociety Delphi consensus statement on new fatty liver disease nomenclature von Rinella, Mary E, Lazarus, Jeffrey V, Ratziu, Vlad, Francque, Sven M, Sanyal, Arun J, Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F, Anstee, Quentin M, Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D, Castro Narro, Graciela E, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R, Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D, Harrison, Stephen A, Kim, Seung Up, Koot, Bart G, Korenjak, Marko, Kowdley, Kris V, Lacaille, Florence, Loomba, Rohit, Mitchell-Thain, Robert, Morgan, Timothy R, Powell, Elisabeth E, Roden, Michael, Romero-Gómez, Manuel, Silva, Marcelo, Singh, Shivaram Prasad, Sookoian, Silvia C, Spearman, C Wendy, Tiniakos, Dina, Valenti, Luca, Vos, Miriam B, Wong, Vincent Wai-Sun, Xanthakos, Stavra, Yilmaz, Yusuf, Younossi, Zobair, Hobbs, Ansley, Villota-Rivas, Marcela, Newsome, Philip N

Volltext

Non-alcoholic fatty liver disease and the interface between primary and secondary care von Tsochatzis, Emmanuel A, Newsome, Philip N

Volltext